A 26-year FDA scientist and administrator, Pazdur has headed the agency's Oncology Center of Excellence since its creation in ...

Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...

Recommendations for optimal gestational weight gain are different depending on a woman's body mass index (BMI), ranging from ...

The investigational Bruton's tyrosine kinase inhibitor fenebrutinib reduced annualized relapse rates versus teriflunomide ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

In Texas, cases of pertussis, or whooping cough, have reached an 11-year-high, even before the end of the respiratory illness ...

New analyses of an investigational high-dose semaglutide pill for obesity showed improvements in blood sugar control and ...

NEW ORLEANS -- A program in which Dietary Approaches to Stop Hypertension (DASH)-style groceries were delivered to residents ...

The DESTINY-Breast11 (DB-11) and DESTINY-Breast05 (DB-05) trials, presented at the European Society for Medical Oncology ...

ORLANDO -- Long-term results from trials of new drugs for hereditary angioedema (HAE) continue to support efficacy and safety ...

WASHINGTON -- Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of ...